MOLECULAR THERAPEUTICS Trademark

Trademark Overview

On Wednesday, December 8, 2004, a trademark application was filed for MOLECULAR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MOLECULAR THERAPEUTICS trademark a serial number of 78529025. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 20, 2017. This trademark is owned by Molecular Therapeutics. The MOLECULAR THERAPEUTICS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Distributorship services in the field of pharmaceutical products
molecular therapeutics

General Information

Serial Number78529025
Word MarkMOLECULAR THERAPEUTICS
Filing DateWednesday, December 8, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 20, 2017
Registration Number3103317
Registration DateTuesday, June 13, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2006

Trademark Statements

Disclaimer with Predetermined Text"Therapeutics"
Goods and ServicesDistributorship services in the field of pharmaceutical products

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 20, 2017
Primary Code035
First Use Anywhere DateSunday, July 1, 2001
First Use In Commerce DateSaturday, September 1, 2001

Trademark Owner History

Party NameMolecular Therapeutics
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressAthens, GA 30602
Party NameMolecular Therapeutics
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressAthens, GA 30602
Party NameMolecular Therapeutics
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressAthens, GA 30602

Trademark Events

Event DateEvent Description
Friday, January 20, 2017CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, June 13, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, September 10, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, September 10, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 7, 2012TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, June 29, 2012POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Friday, June 29, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 25, 2012TEAS SECTION 8 & 15 RECEIVED
Monday, June 25, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 13, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, March 21, 2006PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2006NOTICE OF PUBLICATION
Friday, February 3, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 27, 2006ASSIGNED TO LIE
Monday, January 23, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 23, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 13, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 13, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 17, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 10, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 10, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 13, 2005NON-FINAL ACTION E-MAILED
Wednesday, July 13, 2005NON-FINAL ACTION WRITTEN
Wednesday, July 13, 2005ASSIGNED TO EXAMINER
Friday, December 17, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics molecular products pharmaceutical field services distributorship